Therapeutic Potential of Gingival mesenchymal Stem Cell-derived Extracellular Vesicles Enriched with MFG-E8 in Peripheral Nerve Regeneration
富含 MFG-E8 的牙龈间充质干细胞来源的细胞外囊泡在周围神经再生中的治疗潜力
基本信息
- 批准号:10042927
- 负责人:
- 金额:$ 20.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAnti-Inflammatory AgentsApoptoticApplications GrantsAutologous TransplantationBiological ProcessCell TherapyCellsCerebral IschemiaCicatrixClinicClinicalClinical TrialsCollagenComplexCrush InjuryCustomDataDefectDiseaseEpidermal Growth FactorEvaluationFactor VIIIFemaleGene ExpressionGenesGeneticGenetic TranscriptionGingivaGlycoproteinsGoalsGoldHistologicHomeostasisHumanHydrogelsImplantInfectionInferiorInflammationInfusion proceduresJUN geneLeadLipidsMediatingMesenchymal Stem CellsModelingMorbidity - disease rateMusNatural regenerationNerveNerve RegenerationNeurodegenerative DisordersNeurogliaNeuromaOperative Surgical ProceduresOutcomePeripheral NervesPeripheral nerve injuryPhagocytosisPharmacologyPhenotypePlayProteinsProteomicsRadialRattusRegenerative MedicineRegulationRoleSTAT3 geneSafetySchwann CellsSensorySignal PathwaySiteTaste BudsTestingTherapeuticTherapeutic EffectTissue EngineeringTongueTransplantationTreatment EfficacyUntranslated RNAafferent nervebasecell motilitycombinatorialexosomeextracellular vesiclesimmunoregulationimprovedintercellular communicationmalemilk fat globulenerve autograftnerve injurynerve stem cellneurogenesisnovelnovel strategiesnovel therapeuticsparticleperipheral nerve regenerationpleiotropismreconstructionregenerativeregenerative therapyrepairedresponse to injurysciatic nerveself-renewalsmall hairpin RNAstandard carestem cellstissue regeneration
项目摘要
PROJECT SUMMARY/ABSTRACT
Peripheral nerve injury (PNI) is a common and complex clinical challenge. Nerve autografts remain the “gold
standard” for reconstruction of PNI with a large gap, but limited availability of donor nerves and several severe
donor site morbidities significantly impede their clinic application. The combinatorial use of tissue engineered
nerve guidance conduits (NGCs) with supportive cells and bioactive factors has the potential to be alternatives
to nerve autografts. Mesenchymal stem cell (MSC)-based therapy has shown promises in regenerative
medicine due to their multipotent, immunomodulatory/anti-inflammatory, and regenerative potentials. The
therapeutic effects of MSCs most probably rely on their secretome, particularly the secretory extracellular
vesicles (EVs) which play important roles in intercellular communication through transfer of various bioactive
molecules e.g. lipids, proteins, and noncoding RNAs. Due to their comparable therapeutic efficacy to parental
cells, MSC-EVs have been explored as novel cell-free therapeutics for a spectrum of diseases. However, the
potential use of MSC-EVs in peripheral nerve regeneration remains largely unexplored. We have recently
shown that human gingiva-derived MSCs (GMSCs) and their released EVs displayed comparable therapeutic
effects on regeneration of taste bud/taste sensory nerves of rats and repair/regeneration of crush-injured
sciatic nerves of mice possibly by promoting reprogramming of myelinated Schwann cells toward a repair
phenotype. Our preliminary study showed that infusion of GMSC-EVs into the customized AxoGuard Nerve
Connectors significantly improved their efficacy on regeneration of transected rat sciatic nerves. Through
proteomic profiling, we identified a group of protein factors significantly enriched in GMSC-EVs, among which
milk fat globule-epidermal growth factor-factor VIII (MFG-E8) is particularly interesting because of its pleiotropic
biological functions. Our preliminary data also showed that MFG-E8 activated pSTAT3 and upregulated gene
expressions involved in regulating repair phonotypic conversion of Schwann cells. We hypothesize that
enriched MFG-E8 contributes a major role in GMSC-EVs mediated therapeutic effects on nerve regeneration
by promoting the repair phenotypic conversion of Schwann cells. We proposed two specific aims to test the
hypothesis: 1) determine the pleiotropic effects of MFG-E8 enriched in GMSC-EVs on the repair phenotypic
conversion of Schwann cells; 2) investigate the critical role of MFG-E8 in GMSC EV-mediated therapeutic
effects on regeneration of transected rat sciatic nerves. Our long-term goal is to develop a cell-free/stem cell-
based product as a potential alternative to nerve autografts for regeneration of PNI with a large gap. Results
from this study will lead us to submit an R01 grant application that will allow us to better understand the
mechanisms underlying MSC-EV mediated therapeutic effects on nerve regeneration and to further explore the
safety and efficacy of MSC-EVs in nerve regeneration in large animals and early human clinical trials.
项目总结/摘要
周围神经损伤(PNI)是一种常见而复杂的临床挑战。自体神经移植仍然是“黄金
对于具有较大间隙的PNI重建,“标准”,但供体神经的可用性有限,
供体部位的发病率显著阻碍了它们的临床应用。组织工程的组合应用
具有支持细胞和生物活性因子的神经引导导管(NGC)具有成为替代物的潜力
神经自体移植间充质干细胞(MSC)为基础的治疗已显示出再生的承诺,
由于其多能性、免疫调节/抗炎和再生潜力,的
MSC的治疗作用最可能依赖于它们的分泌组,特别是分泌性细胞外基质。
囊泡(EV)通过传递各种生物活性物质在细胞间通讯中发挥重要作用,
分子,例如脂质、蛋白质和非编码RNA。由于其治疗效果与母体药物相当,
细胞,MSC-EV已被探索为一系列疾病的新型无细胞治疗剂。但
MSC-EV在周围神经再生中的潜在用途仍然在很大程度上未被探索。我们最近
显示人牙龈来源的MSC(GMSC)及其释放的EV显示出相当的治疗效果,
对大鼠味蕾/味觉神经再生和挤压损伤修复/再生的影响
可能通过促进有髓鞘雪旺细胞的重编程来修复小鼠坐骨神经
表型我们的初步研究表明,将GMSC-EV注入定制的AxoGuard Nerve
连接器显着提高其对大鼠坐骨神经横断再生的功效。通过
通过蛋白质组分析,我们鉴定了一组在GMSC-EV中显著富集的蛋白质因子,其中
乳脂球-表皮生长因子-因子VIII(MFG-E8)由于其多效性而特别令人感兴趣
生物功能。我们的初步数据还表明MFG-E8激活pSTAT 3,上调基因表达。
参与调节雪旺氏细胞的修复声型转换的表达。我们假设
富集的MFG-E8在GMSC-EV介导的对神经再生的治疗作用中起主要作用
通过促进许旺细胞的修复表型转化。我们提出了两个具体目标,以测试
假设:1)确定富含GMSC-EV的MFG-E8对修复表型的多效性作用,
2)研究MFG-E8在GMSC EV介导的治疗性转化中的关键作用;
对切断的大鼠坐骨神经再生的影响。我们的长期目标是开发无细胞/干细胞-
的产品作为自体神经移植物的潜在替代品,用于具有大间隙的PNI的再生。结果
从这项研究将导致我们提交R 01赠款申请,这将使我们能够更好地了解
MSC-EV介导的神经再生治疗作用的机制并进一步探索
MSC-EV在大型动物和早期人类临床试验中神经再生的安全性和有效性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anh D Le其他文献
Anh D Le的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anh D Le', 18)}}的其他基金
Targeted inhibition of eIF5Ahpu suppresses tumor growth and M2-like TAM polarization in oral cancer
靶向抑制 eIF5Ahpu 可抑制口腔癌中的肿瘤生长和 M2 样 TAM 极化
- 批准号:
10573290 - 财政年份:2022
- 资助金额:
$ 20.25万 - 项目类别:
Targeted inhibition of eIF5Ahpu suppresses tumor growth and M2-like TAM polarization in oral cancer
靶向抑制 eIF5Ahpu 可抑制口腔癌中的肿瘤生长和 M2 样 TAM 极化
- 批准号:
10441837 - 财政年份:2022
- 资助金额:
$ 20.25万 - 项目类别:
Therapeutic Potential of Gingival mesenchymal Stem Cell-derived Extracellular Vesicles Enriched with MFG-E8 in Peripheral Nerve Regeneration
富含 MFG-E8 的牙龈间充质干细胞来源的细胞外囊泡在周围神经再生中的治疗潜力
- 批准号:
10180941 - 财政年份:2020
- 资助金额:
$ 20.25万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
7728606 - 财政年份:2009
- 资助金额:
$ 20.25万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
8271275 - 财政年份:2009
- 资助金额:
$ 20.25万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
7851425 - 财政年份:2009
- 资助金额:
$ 20.25万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
8070529 - 财政年份:2009
- 资助金额:
$ 20.25万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
8600475 - 财政年份:2009
- 资助金额:
$ 20.25万 - 项目类别:
GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION
牙龈源性间充质干细胞:在免疫调节和组织再生中的作用
- 批准号:
8466720 - 财政年份:2009
- 资助金额:
$ 20.25万 - 项目类别:
BOWMAN-BIRK INHIBITOR CONCENTRATE & ORAL LEUKOPLAKIA: PHASE IIB TRIAL (UNIVER
BOWMAN-BIRK 抑制剂浓缩液
- 批准号:
7716696 - 财政年份:2008
- 资助金额:
$ 20.25万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 20.25万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 20.25万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 20.25万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 20.25万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 20.25万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 20.25万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 20.25万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 20.25万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 20.25万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 20.25万 - 项目类别: